Search in:

Advanced search

International Journal of Nanomedicine Volume 11, 2016 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition

Guixia Ling1 Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, People’s Republic of China

Tianhong Zhang2 Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, People’s Republic of China

Peng Zhang2 Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, People’s Republic of ChinaCorrespondence[email protected]

Jin Sun1 Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, People’s Republic of China

Zhonggui He1 Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, People’s Republic of China

Pages 4077-4091 | Published online: 23 Aug 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Reference

ZhangPLingGPanXNovel nanostructured lipid-dextran sulfate hybrid carriers (NLDCs) overcome tumor multidrug resistance of mitoxantrone hydrochlorideNanomedicine20128218519321704599
PubMed Web of Science ®Google Scholar

References

IyerAKSinghAGantaSAmijiMMRole of integrated cancer nanomedicine in overcoming drug resistanceAdv Drug Deliv Rev2013651784180223880506
PubMed Web of Science ®Google Scholar
DonnenbergVSDonnenbergADMultiple drug resistance in cancer revisited: the cancer stem cell hypothesisJ Clin Pharmacol20054587287716027397
PubMed Web of Science ®Google Scholar
SteinWDBatesSEFojoTIntractable cancers: the many faces of multidrug resistance and the many targets it presents for therapeutic attackCurr Drug Targets2004533334615134216
PubMed Web of Science ®Google Scholar
DuhemCRiesFDicatoMWhat does multidrug resistance (MDR) expression mean in the clinic?Oncologist1996115115810387981
PubMedGoogle Scholar
DeanMAllikmetsRComplete characterization of the human ABC gene familyJ Bioenerg Biomembr20013347547911804189
PubMed Web of Science ®Google Scholar
KirkinVJoosSZörnigMThe role of Bcl-2 family members in tumorigenesisBiochim Biophys Acta2004164422924914996506
PubMed Web of Science ®Google Scholar
GottesmanMMFojoTBatesSEMultidrug resistance in cancer: role of ATP-dependent transportersNat Rev Cancer20022485811902585
PubMed Web of Science ®Google Scholar
KhalafAPfisterCHellotMFDunetFMoussuJGrisePValue of mitoxantrone in metastatic hormone-resistant prostate cancerProg Urol200212374211980013
PubMed Web of Science ®Google Scholar
HagemeisterFCabanillasFColemanMGregorySAZinzaniPLThe role of mitoxantrone in the treatment of indolent lymphomasOncologist20051015015915709217
PubMed Web of Science ®Google Scholar
NovoselacAVReddySSanmugarajahJAcute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantroneLeukemia2004181561156215215874
PubMed Web of Science ®Google Scholar
DoyleLAYangWAbruzzoLVA multidrug resistance transporter from human MCF-7 breast cancer cellsProc Natl Acad Sci U S A19989515665156709861027
PubMed Web of Science ®Google Scholar
MaliepaardMvan GastelenMAde JongLAOverexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell lineCancer Res1999594559456310493507
PubMed Web of Science ®Google Scholar
KangKWChunMKKimODoxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapyNanomedicine2010621021320060074
PubMed Web of Science ®Google Scholar
MüllerRHRadtkeMWissingSANanostructured lipid matrices for improved microencapsulation of drugsInt J Pharm200224212112812176234
PubMed Web of Science ®Google Scholar
RicciMPugliaCBoninaFDi GiovanniCGiovagnoliSRossiCEvaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studiesJ Pharm Sci2005941149115915793804
PubMed Web of Science ®Google Scholar
YuanHWangLLDuYZYouJHuFQZengSPreparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsificationColloids Surf B Biointerfaces20076017417917656075
PubMed Web of Science ®Google Scholar
ZhangPLingGPanXNovel nanostructured lipid-dextran sulfate hybrid carriers (NLDCs) overcome tumor multidrug resistance of mitoxantrone hydrochlorideNanomedicine20128218519321704599
PubMed Web of Science ®Google Scholar
KathawalaRJGuptaPAshbyCRJrChenZ-SThe modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decadeDrug Resist Updat20151811725554624
PubMed Web of Science ®Google Scholar
LiLYaoQQXuSYCyclosporin A affects the bioavailability of ginkgolic acids via inhibition of P-gp and BCRPEur J Pharm Biopharm201488375976724980806
PubMedGoogle Scholar
LoYLHoCTTsaiFLInhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicinEur J Pharm Sci200835526718606222
PubMed Web of Science ®Google Scholar
ZhangPLingGXSunJDetermination of mitoxantrone in rat plasma by liquid chromatography-tandem mass spectrometry method: application to a pharmacokinetic studyJ Chromatogr B Analyt Technol Biomed Life Sci201087822602265
PubMed Web of Science ®Google Scholar
SongXCaiZZhengYReversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticlesEur J Pharm Sci20093730030519491019
PubMed Web of Science ®Google Scholar
WangYLuXLuWZhangCLiangWPegylated phospholipids-based self-assembly with water-soluble drugsPharm Res20102736137020033475
PubMed Web of Science ®Google Scholar
LiYTaulierNRauthAMWuXScreening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN)Pharm Res2006231877188716850265
PubMed Web of Science ®Google Scholar
LingGZhangPZhangWDevelopment of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibitionJ Control Release201014824124820727928
PubMed Web of Science ®Google Scholar
ZhangPLingGSunJMultifunctional nanoassemblies for vincristine sulfate delivery to overcome multidrug resistance by escaping P-glycoprotein mediated effluxBiomaterials201132235524553321546082
PubMed Web of Science ®Google Scholar
LiYQWongHLShuhendlerAJRauthAMWuXYMolecular interactions, internal structure and drug release kinetics of rationally developed polymer–lipid hybrid nanoparticlesJ Control Release2008128607018406489
PubMed Web of Science ®Google Scholar
WongHLRauthAMBendayanRA new polymer–lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cellsPharm Res2006231574158516786442
PubMed Web of Science ®Google Scholar
WongHLBendayanRRauthAMWuXYSimultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer–lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancerJ Control Release200611627528417097178
PubMed Web of Science ®Google Scholar
JacobsCKayserOMüllerRHNanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepideInt J Pharm2000196216116410699709
PubMed Web of Science ®Google Scholar
ShahREldridgeDPalomboEHardingICharacterizationLipid Nanoparticles: Production, Characterization and StabilitySpringer-Briefs in Pharmaceutical Science & Drug Development20154574
Google Scholar
ShahRMMalherbeFEldridgeDPalomboEAHardingIHPhysicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion techniqueJ Colloid Interface Sci201442828629424910064
PubMed Web of Science ®Google Scholar
KovačevićaABMüllerbRHSavićaSDVuletaaGMKeckCMSolid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: preparation, characterization and physical stability investigationColloids Surfaces A: Physicochem Eng Aspects20144441525
Google Scholar
MussiSVSilvaRCOliveiraMCLucciCMAzevedoRBFerreiraLANew approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticlesEur J Pharm Sci2013481–228229023178339
PubMed Web of Science ®Google Scholar
SezerADAkbugaJBasALIn vitro evaluation of enrofloxacinloaded MLV liposomesDrug Deliv200714475317107930
PubMed Web of Science ®Google Scholar
MuthuMSSinghSPoly (D, L-lactide) nanosuspensions of risperidone for parenteral delivery: formulation and in-vitro evaluationCurr Drug Deliv20096626819418957
PubMedGoogle Scholar
D’SouzaSSDeLucaPPMethods to assess in vitro drug release from injectable polymeric particulate systemsPharm Res20062346047416400516
PubMed Web of Science ®Google Scholar
MartinsSThoIReimoldIBrain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studiesInt J Pharm20124391–2496223046667
PubMedGoogle Scholar
SunJBiCChanHMSunSZhangQZhengYCurcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailabilityColloids Surf B Biointerfaces201311136737523856543
PubMed Web of Science ®Google Scholar
WangDKongLWangJHeXLiXXiaoYPolymyxin E sulfate-loaded liposome for intravenous use: preparation, lyophilization, and toxicity assessment in vivoPDA J Pharm Sci Technol20096315916719634354
PubMedGoogle Scholar
BoydBJCharacterisation of drug release from cubosomes using the pressure ultrafiltration methodInt J Pharm2003260223924712842343
PubMed Web of Science ®Google Scholar
WallaceSJLiJNationRLBoydBJDrug release from nanomedicines: selection of appropriate encapsulation and release methodologyDrug Deliv Transl Res20122428429223110256
PubMed Web of Science ®Google Scholar
FauldsDBalfourJAChrispPLangtryHDMitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancerDrugs1991414004491711446
PubMed Web of Science ®Google Scholar
KeefeDLAnthracycline-induced cardiomyopathySemin Oncol2001282711552224
PubMed Web of Science ®Google Scholar
JainKKEvaluation of mitoxantrone for the treatment of multiple sclerosisExpert Opin Investig Drugs2000911391149
PubMed Web of Science ®Google Scholar
RentschKMHorberDHSchwendenerRAWunderli-AllenspachHHänselerEComparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in miceBr J Cancer1997759869929083333
PubMedGoogle Scholar
SahayGAlakhovaDYKabanovAVEndocytosis of nanomedicinesJ Controlled Release20101453182195
PubMed Web of Science ®Google Scholar
ChaiGHHuFQSunJDuYZYouJYuanHTransport pathways of solid lipid nanoparticles across Madin-Darby canine kidney epithelial cell monolayerMol Pharm201411103716372625197948
PubMed Web of Science ®Google Scholar
MartinsSCosta-LimaSCarneiroTCordeiro-da-SilvaASoutoEBFerreiraDCSolid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathwayInt J Pharm20124301–221622722465548
PubMed Web of Science ®Google Scholar
McMahonHTBoucrotEMolecular mechanism and physiological functions of clathrin-mediated endocytosisNat Rev Mol Cell Biol201112851753321779028
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition

Reference

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Synergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition

Reference

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date